193 related articles for article (PubMed ID: 17877064)
1. Fibrotest-Actitest: the biochemical marker of liver fibrosis--the Israeli experience.
Morali G; Maor Y; Klar R; Braun M; Ben Ari Z; Bujanover Y; Zuckerman E; Boger S; Halfon P
Isr Med Assoc J; 2007 Aug; 9(8):588-91. PubMed ID: 17877064
[TBL] [Abstract][Full Text] [Related]
2. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
[TBL] [Abstract][Full Text] [Related]
3. Impact of quality control accepted inter-laboratory variations on calculated Fibrotest/Actitest scores for the non-invasive biochemical assessment of liver fibrosis.
Gressner OA; Beer N; Jodlowski A; Gressner AM
Clin Chim Acta; 2009 Nov; 409(1-2):90-5. PubMed ID: 19748500
[TBL] [Abstract][Full Text] [Related]
4. Correlation between liver biopsy and fibrotest in the evaluation of hepatic fibrosis in patients with chronic hepatitis C.
Said Y; Salem M; Mouelhi L; Mekki H; Houissa F; Ben Rejeb M; Moussa A; Trabelsi S; Debbeche R; Bouzaidi S; Najjar T
Tunis Med; 2010 Aug; 88(8):573-8. PubMed ID: 20711964
[TBL] [Abstract][Full Text] [Related]
5. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study.
Imbert-Bismut F; Ratziu V; Pieroni L; Charlotte F; Benhamou Y; Poynard T;
Lancet; 2001 Apr; 357(9262):1069-75. PubMed ID: 11297957
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease.
Ratziu V; Massard J; Charlotte F; Messous D; Imbert-Bismut F; Bonyhay L; Tahiri M; Munteanu M; Thabut D; Cadranel JF; Le Bail B; de Ledinghen V; Poynard T; ;
BMC Gastroenterol; 2006 Feb; 6():6. PubMed ID: 16503961
[TBL] [Abstract][Full Text] [Related]
7. Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.
Myers RP; Ratziu V; Imbert-Bismut F; Charlotte F; Poynard T;
Am J Gastroenterol; 2002 Sep; 97(9):2419-25. PubMed ID: 12358267
[TBL] [Abstract][Full Text] [Related]
8. [FibroTest-ActiTest for predicting liver fibrosis and inflammatory activity in Chinese patients with chronic hepatitis B].
Gui HL; Xie Q; Wang H
Zhonghua Gan Zang Bing Za Zhi; 2008 Dec; 16(12):897-901. PubMed ID: 19105932
[TBL] [Abstract][Full Text] [Related]
9. Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large population.
Poynard T; Munteanu M; Deckmyn O; Ngo Y; Drane F; Castille JM; Housset C; Ratziu V; Imbert-Bismut F
J Hepatol; 2012 Sep; 57(3):541-8. PubMed ID: 22612998
[TBL] [Abstract][Full Text] [Related]
10. FibroTest-ActiTest as a non-invasive marker of liver fibrosis.
Halfon P; Munteanu M; Poynard T
Gastroenterol Clin Biol; 2008 Sep; 32(6 Suppl 1):22-39. PubMed ID: 18973844
[TBL] [Abstract][Full Text] [Related]
11. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
Zaman A; Rosen HR; Ingram K; Corless CL; Oh E; Smith K
Am J Med; 2007 Mar; 120(3):280.e9-14. PubMed ID: 17349453
[TBL] [Abstract][Full Text] [Related]
12. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.
Leroy V; Hilleret MN; Sturm N; Trocme C; Renversez JC; Faure P; Morel F; Zarski JP
J Hepatol; 2007 May; 46(5):775-82. PubMed ID: 17321634
[TBL] [Abstract][Full Text] [Related]
13. Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors.
Imbert-Bismut F; Messous D; Thibault V; Myers RB; Piton A; Thabut D; Devers L; Hainque B; Mercadier A; Poynard T
Clin Chem Lab Med; 2004 Mar; 42(3):323-33. PubMed ID: 15080567
[TBL] [Abstract][Full Text] [Related]
14. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R
J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
[TBL] [Abstract][Full Text] [Related]
16. Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis.
Alric L; Kamar N; Bonnet D; Danjoux M; Abravanel F; Lauwers-Cances V; Rostaing L
Transpl Int; 2009 May; 22(5):568-73. PubMed ID: 19196449
[TBL] [Abstract][Full Text] [Related]
17. Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study.
Halfon P; Bourliere M; Deydier R; Botta-Fridlund D; Renou C; Tran A; Portal I; Allemand I; Bertrand JJ; Rosenthal-Allieri A; Rotily M; Sattonet C; Benderitter T; Saint Paul MC; Bonnot HP; Penaranda G; Degott C; Masseyeff MF; Ouzan D
Am J Gastroenterol; 2006 Mar; 101(3):547-55. PubMed ID: 16542291
[TBL] [Abstract][Full Text] [Related]
18. A novel panel of blood markers to assess the degree of liver fibrosis.
Calès P; Oberti F; Michalak S; Hubert-Fouchard I; Rousselet MC; Konaté A; Gallois Y; Ternisien C; Chevailler A; Lunel F
Hepatology; 2005 Dec; 42(6):1373-81. PubMed ID: 16317693
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Fibrotest and PGAA for the diagnosis of fibrosis stage in patients with alcoholic liver disease.
Naveau S; Essoh BM; Ghinoiu M; Marthey L; Njiké-Nakseu M; Balian A; Lachgar M; Prévot S; Perlemuter G
Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):404-11. PubMed ID: 24561990
[TBL] [Abstract][Full Text] [Related]
20. The FibroTest value in discriminating between insignificant and significant fibrosis in chronic hepatitis C patients. The Romanian experience.
Grigorescu M; Rusu M; Neculoiu D; Radu C; Serban A; Catanas M; Grigorescu MD
J Gastrointestin Liver Dis; 2007 Mar; 16(1):31-7. PubMed ID: 17410286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
